ALMR
Alamar Biosciences, Inc. Common Stock
NASDAQ: ALMR · HEALTHCARE · MEDICAL DEVICES
$25.04
+2.29% today
Updated 2026-04-30
Market cap
$1.67B
P/E ratio
—
P/S ratio
22.50x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$17 – $27
Volume
0.9M
Alamar Biosciences, Inc. Common Stock (ALMR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | $25.14M | $74.21M |
| Revenue growth (YoY) | — | +195.2% |
| Cost of revenue | $16.54M | $32.51M |
| Gross profit | $8.61M | $41.70M |
| Gross margin | 34.2% | 56.2% |
| R&D | $39.23M | $37.47M |
| SG&A | $18.94M | $35.57M |
| Operating income | $-49.57M | $-31.33M |
| Operating margin | -197.2% | -42.2% |
| EBITDA | — | — |
| EBITDA margin | 0.0% | 0.0% |
| EBIT | — | — |
| Interest expense | $2.08M | $401000.00 |
| Income tax | — | — |
| Effective tax rate | 0.0% | 0.0% |
| Net income | $-47.07M | $-29.82M |
| Net income growth (YoY) | — | +36.7% |
| Profit margin | -187.2% | -40.2% |